Stakeholders Urge FDA To Proceed With Single-Page Medication Information

Stakeholders recently urged FDA to move forward on plans to develop a single-page patient medication information (PMI) leaflet to accompany prescription drugs, replacing the multiple pages of information, but several said FDA's approach should be flexible because one format might not be optimal for all drugs. The issue came up at a meeting last Tuesday (July 1) hosted by FDA and Brookings Institution's Engelberg Center for Health Care Reform to highlight progress on the development of a standardized format for...